Witherspoon Charles
SEC CIK 1731739 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WST | West Pharmaceutical Services | VP, Treas | 1,408 | — | $2.64M | 20 | 2023-02-21 | 2026-02-20 |
Most active insiders at WST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Favorite Annette F | SVP, Chief HR Off | — | $6.30M |
| 2 | Winters Chad | VP, CAO | — | $269.4K |
| 3 | Poussot Rodolphe Jean | SVP, Strategy, Corp. Dev | — | — |
| 4 | Campbell Shane Alden | SVP, Proprietary Segment | — | — |
| 5 | Lockhart Stephen H | Dir | — | — |
| 6 | Witherspoon Charles | VP, Treas | — | — |
| 7 | Joseph Molly | Dir | — | — |
| 8 | McMahon Robert W. | SVP, CFO | — | — |
| 9 | Feehery William F | Dir | — | — |
| 10 | Pucci Paolo | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-23 | 2026-02-20 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | F - Tax | $241.12 | -22.07 | 1,408 | -2% | -$5,322 |
| D | 2026-02-23 | 2026-02-20 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | M - OptEx | — | +60.22 | 1,430 | +4% | — |
| 2026-02-19 | 2026-02-17 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | F - Tax | $243.19 | -41.52 | 1,370 | -3% | -$10.1K | |
| 2026-02-19 | 2026-02-17 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | A - Grant | $0.00 | +115.91 | 1,411 | +9% | $0 | |
| D | 2025-02-20 | 2025-02-18 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | M - OptEx | $211.00 | +65.71 | 1,319 | +5% | +$13.9K |
| D | 2025-02-20 | 2025-02-18 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | F - Tax | $211.00 | -23.49 | 1,295 | -2% | -$4,956 |
| DM | 2024-10-31 | 2024-10-29 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | S - Sale+OE | $310.40 | -703 | 1,478 | -32% | -$218.2K |
| D | 2024-10-31 | 2024-10-29 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | M - OptEx | $173.22 | +478 | 1,956 | +32% | +$82.8K |
| DM | 2024-08-21 | 2024-08-19 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | S - Sale+OE | $300.00 | -1,029 | 1,978 | -34% | -$308.7K |
| D | 2024-08-21 | 2024-08-19 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | M - OptEx | $102.51 | +529 | 2,507 | +27% | +$54.2K |
| D | 2024-03-01 | 2024-02-28 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | S - Sale+OE | $358.62 | -2,019 | 1,979 | -50% | -$724.1K |
| D | 2024-03-01 | 2024-02-28 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | M - OptEx | $102.51 | +2,019 | 3,998 | +102% | +$207.0K |
| D | 2024-02-22 | 2024-02-20 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | A - Grant | $0.00 | +144 | 1,979 | +8% | $0 |
| DM | 2023-11-02 | 2023-10-31 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | M - OptEx | $223.84 | +1,190 | 3,025 | +65% | +$266.4K |
| DM | 2023-11-02 | 2023-10-31 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | S - Sale+OE | $322.37 | -1,190 | 1,835 | -39% | -$383.6K |
| DM | 2023-08-11 | 2023-08-09 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | M - OptEx | $137.87 | +1,680 | 3,510 | +92% | +$231.6K |
| D | 2023-08-11 | 2023-08-09 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | S - Sale+OE | $396.54 | -1,680 | 1,830 | -48% | -$666.2K |
| D | 2023-05-31 | 2023-05-30 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | M - OptEx | $102.51 | +1,000 | 2,830 | +55% | +$102.5K |
| D | 2023-05-31 | 2023-05-30 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | S - Sale+OE | $343.05 | -1,000 | 1,830 | -35% | -$343.1K |
| D | 2023-02-23 | 2023-02-21 | WST | West Pharmaceutical Services | Witherspoon Charles | VP, Treas | A - Grant | $306.68 | +407 | 1,830 | +29% | +$124.8K |
Purchase Sale Sale after option exercise All abbreviations